ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Internal Medicine

Top Internal Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JONATHAN HAYDEN M.D.

Internal Medicine

1,923

$100K

193
171 are 65+

6%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $63

CAROLYN TAYLOR-OLSON MD

Internal Medicine

1,825

$82.6K

92
84 are 65+

23%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $63

JUAN CARLOS NUNEZ MEDINA M.D.

Internal Medicine

1,813

$75.6K

159
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $63

RICHARD PINCKNEY MD

Internal Medicine

1,762

$163K

349
219 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$93
Average prescription price

Avg: $63

CHRISTINE NORTHRUP MD

Internal Medicine

1,718

$129K

86
78 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $63

CLAUDIA LEE M.D.

Internal Medicine

1,692

$111K

195
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $63

JUN FU M.D.

Internal Medicine

1,647

$79.4K

173
124 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $63

HALLE SOBEL MD

Internal Medicine

1,644

$155K

151
81 are 65+

16%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$94
Average prescription price

Avg: $63

THEODORE FINK MD

Internal Medicine

1,644

$103K

127
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

MARK LEVINE MD

Internal Medicine

1,517

$116K

128
91 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$76
Average prescription price

Avg: $63

ERIC POFCHER M.D.

Internal Medicine

1,482

$122K

206
130 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $63

JENNIFER AYER MD

Internal Medicine

1,386

$103K

156
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $63

MEGAN BATCHELDER M.D.

Internal Medicine

1,305

$87.7K

148
103 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $63

JUDITH STEINBERG M.D.

Internal Medicine

1,180

$63.1K

91
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $63

JENNIFER PETERS M.D.

Internal Medicine

948

$32.6K

180
138 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$34
Average prescription price

Avg: $63

ROSEMARY DALE NP

Internal Medicine

885

$53.2K

138
98 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $63

RICHARD NORMAN MD

Internal Medicine

821

$41.8K

81
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

14%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $63

MIA HOCKETT M.D.

Internal Medicine

728

$43.4K

107
68 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $63

WILLIAM OROURKE M.D.

Internal Medicine

612

$38.8K

91
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

SCOTT HUNTER PAC

Internal Medicine

538

$25.3K

221
157 are 65+

6%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $63

STEPHEN GORMAN M.D.

Internal Medicine

436

$118K

98
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 22%

$271
Average prescription price

Avg: $63

LUTHER EMERSON M.D.

Internal Medicine

280

$18.6K

65
62 are 65+

49%
patients receiving schedule two controlled substances

Avg: 10%

26%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank